These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 18638591)

  • 21. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized comparison of sirolimus- vs. paclitaxel-eluting stents for treatment of bifurcation lesions by single stent and kissing balloon: results of the SINGLE KISS trial.
    Nasu K; Oikawa Y; Yoshikawa R; Kadotani M; Takeda Y; Ota H; Kamiya H; Muto M; Okamura A; Yamaki M; Usui S; Tohara S; Yamashita J; Suzuki M; Kawaguchi R; Kawajiri K; Nakatsu Y; Uchida Y; Kashima Y; Kawashima N; Ozaki T; Ogawa T; Aizawa T; Suzuki T;
    Int J Cardiol; 2013 Jun; 166(1):187-92. PubMed ID: 22075412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravascular ultrasound assessment of expansion of the sirolimus-eluting (cypher select) and paclitaxel-eluting (Taxus Express-2) stent in patients with diabetes mellitus.
    Jensen LO; Maeng M; Mintz GS; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Hansen HS; Joergensen E; Lassen JF; Thuesen L; Thayssen P
    Am J Cardiol; 2008 Jul; 102(1):19-26. PubMed ID: 18572030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial.
    Chevalier B; Di Mario C; Neumann FJ; Ribichini F; Urban P; Popma JJ; Fitzgerald PJ; Cutlip DE; Williams DO; Ormiston J; Grube E; Whitbourn R; Schwartz LB;
    JACC Cardiovasc Interv; 2008 Oct; 1(5):524-32. PubMed ID: 19463354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.
    Togni M; Eber S; Widmer J; Billinger M; Wenaweser P; Cook S; Vogel R; Seiler C; Eberli FR; Maier W; Corti R; Roffi M; Lüscher TF; Garachemani A; Hess OM; Wandel S; Meier B; Jüni P; Windecker S
    J Am Coll Cardiol; 2007 Sep; 50(12):1123-31. PubMed ID: 17868802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
    J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crush stenting with paclitaxel-eluting or sirolimus-eluting stents for the treatment of coronary bifurcation lesions.
    Chen S; Zhang J; Ye F; Zhu Z; Lin S; Tian N; Liu Z; Fang W; Chen Y; Sun X; Kwan TW
    Angiology; 2008; 59(4):475-83. PubMed ID: 18388098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.
    Adriaenssens T; Dens J; Ughi G; Bennett J; Dubois C; Sinnaeve P; Wiyono S; Coosemans M; Belmans A; D'hooge J; Vrolix M; Desmet W
    EuroIntervention; 2014 Aug; 10(4):439-48. PubMed ID: 25138182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial).
    Hirohata A; Morino Y; Ako J; Sakurai R; Buchbinder M; Caputo RP; Karas SP; Mishkel GJ; Mooney MR; O'shaughnessy CD; Raizner AE; Wilensky RL; Williams DO; Wong SC; Yock PG; Honda Y; Moses JW; Fitzgerald PJ;
    Am J Cardiol; 2006 Dec; 98(11):1464-7. PubMed ID: 17126651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis shows similar risk of thrombosis after drug-eluting stent, bare-metal stent, or angioplasty.
    Fuchs AT; Kuehnl A; Pelisek J; Rolland PH; Mekkaoui C; Netz H; Nikol S
    Endothelium; 2008; 15(1):93-100. PubMed ID: 18568949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents.
    Roy P; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Torguson R; Xue Z; Gevorkian N; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Am J Cardiol; 2007 Sep; 100(6):965-9. PubMed ID: 17826379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up.
    Hong MK; Mintz GS; Lee CW; Park DW; Park KM; Lee BK; Kim YH; Song JM; Han KH; Kang DH; Cheong SS; Song JK; Kim JJ; Park SW; Park SJ
    Circulation; 2006 Jan; 113(3):414-9. PubMed ID: 16432073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
    Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation.
    Song HG; Park DW; Kim YH; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Han S; Seong IW; Lee NH; Lee BK; Lee K; Lee SW; Nah DY; Park SJ
    J Am Coll Cardiol; 2012 Mar; 59(12):1093-100. PubMed ID: 22421303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Mahaffey KW; Cutlip DE; Fitzgerald PJ; Sood P; Su X; Lansky AJ;
    JAMA; 2008 Apr; 299(16):1903-13. PubMed ID: 18430909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.
    Cook S; Wenaweser P; Togni M; Billinger M; Morger C; Seiler C; Vogel R; Hess O; Meier B; Windecker S
    Circulation; 2007 May; 115(18):2426-34. PubMed ID: 17485593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform.
    Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A
    Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.